taking tirzepatide every other week Dosing Chart 2026: 2.5-15 mg Titration & Units I compare two weight loss

Description

GIP Mediates the Incretin Effect and Glucose Tolerance by Dual Actions on Alpha and Beta Cells

FDA-labeled warnings include: Risk of thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Pancreatitis (report severe abdominal pain, with or without vomiting) Gallbladder disease (including gallstones and cholecystitis) Acute kidney injury secondary to dehydration from gastrointestinal symptoms Hypoglycemia when used with insulin or insulin secretagogues (dose adjustments may be needed) Diabetic retinopathy complications in patients with type 2 diabetes and pre-existing retinopathy Suicidal behavior and ideation (monitor for depression or suicidal thoughts) Intestinal obstruction/ileus (particularly with severe constipation) These medications are contraindicated during pregnancy and should be discontinued at least two months before a planned pregnancy

Pregnancy Planning Semaglutide is contraindicated during pregnancy and should be stopped at least two months before attempting to conceive

Additional Reported Adverse Effects Beyond gastroparesis and vision loss, patients have reported numerous other serious adverse effects that have led to FDA warning label updates as evidence accumulated